Mrs. Rozhkova graduated from Belarusian State University in 2011 with a degree in Chemistry, specializing in pharmacy. Since 2024, she has been working at the Research Institute of Atherosclerosis as a Clinical Trial Project Manager, particularly focusing on the dietary supplement Tertinat. From 2018 to 2023, Mrs. Rozhkova served as a Clinical Research Specialist at X7 Research, IQVIA, and Medpace, coordinating investigator teams in cardiology, endocrinology, oncology, conducting monitoring, and managing data for drug products like Kinezia®, Ferrum Lek®, Repatha®, and Vectibix®. Earlier roles include translator/editor (2012–2019) for companies such as Roche, GlaxoSmithKline, Novartis, and others, and Research Scientist at LOTIOS (2011–2018), where she developed and validated analytical methods (GC, HPLC, UV-spectrometry) and assisted in clinical trials for Gamastat® and Gamaferron
Oral Presentation(In-Person)